Clinical assessment of radiotherapy-induced vaginal toxicity with multiparametric ultrasound imaging
Project Number1R21CA290252-01
Contact PI/Project LeaderBURGESS, MARK THOMAS
Awardee OrganizationSLOAN-KETTERING INST CAN RESEARCH
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Pelvic radiotherapy is the standard of care for numerous gynecological and anorectal cancers affecting
women. Post-operative intravaginal brachytherapy (IVRT) is used to prevent cancer recurrence at the vaginal
cuff for high-intermediate risk endometrial cancer patients. IVRT delivers conformal radiation dose to the
vagina cuff and canal. This results in high rates of acute and late vaginal toxicities, such as vaginal stenosis,
which is defined as the abnormal tightening and shortening of the vagina due to fibrosis. These effects can
lead to debilitating pain, sexual dysfunction, and poor quality of life. Current clinical assessments of vaginal
toxicity are subjective and based on clinician and patient reported grading scales that leads to variability. There
is a clinical need for objective measurements of vaginal tissue health, and we propose a multiparametric
ultrasound imaging approach for vaginal tissue characterization before and after IVRT. In this study, we will
develop a system and methodology for three-dimensional (3D) multiparametric imaging of the vaginal wall
using B-mode, ultrasensitive microvessel imaging (UMI), shear-wave elastography (SWE), and tissue
microstructure characterization with quantitative ultrasound (QUS). As a secondary objective, we will test the
system in a clinical study with fifteen endometrial cancer patients receiving IVRT to identify associations
between multiparametric ultrasound metrics and current clinical assessments of vaginal toxicity. This will be
the first study using a multimodal ultrasound approach for characterization of vaginal tissue. We hypothesize
that multiparametric ultrasound will be produce metrics that are sensitive to anatomical changes (B-mode),
microvascular damage (UMI), fibrosis stage (SWE), and tissue microstructure and cellular death (QUS). There
is increasing awareness of radiation-induced toxicities and considerable effort has gone into strategies to
reduce toxicities and improve overall quality of life and sexual functioning. Multiparametric ultrasound imaging
offers a non-subjective, quantitative approach for detecting and characterizing vaginal health, which is typically
overlooked with current medical imaging. Ultimately, this approach will lead to predictive imaging biomarkers
that clinicians can use as outcome metrics of novel treatment strategies and interventions aimed at preventing
and treating radiotherapy-induced vaginal toxicities. If successful, the research will introduce a safe, cost-
effective imaging platform to improve the health of women suffering from this chronic gynecological condition.
Public Health Relevance Statement
PROJECT NARRATIVE
Radiation-induced vaginal toxicity is a common side effect of pelvic radiotherapy, and no clinical tools exist for
objective, quantitative evaluation of vagina health. The goal of this research project is to develop a system and
methodology for multiparametric ultrasound-based assessment of vaginal toxicity in the acute and late stages
following radiotherapy.
No Sub Projects information available for 1R21CA290252-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21CA290252-01
Patents
No Patents information available for 1R21CA290252-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21CA290252-01
Clinical Studies
No Clinical Studies information available for 1R21CA290252-01
News and More
Related News Releases
No news release information available for 1R21CA290252-01
History
No Historical information available for 1R21CA290252-01
Similar Projects
No Similar Projects information available for 1R21CA290252-01